Form 8-K
8-K — BiomX Inc.
Accession: 0001213900-26-068026
Filed: 2026-06-12
Period: 2026-06-10
CIK: 0001739174
SIC: 2836 (BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES))
Item: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — ea0294507-8k_biomx.htm (Primary)
EX-99.1 — PRESS RELEASE OF BIOMX INC., DATED JUNE 12, 2026 (ea029450701ex99-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0294507-8k_biomx.htm · Sequence: 1
false
0001739174
0001739174
2026-06-10
2026-06-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 10, 2026
BIOMX INC.
(Exact name of registrant as specified in its
charter)
Delaware
001-38762
82-3364020
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
850 New Burton Road, Suite 201
Dover, Delaware 19904
(Address of principal executive offices, including
zip code)
(972) 52-437-4900
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
PHGE
NYSE American
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing
Rule or Standard; Transfer of Listing.
On June 10, 2026, BiomX Inc. (the
“Company”) received a written notice from NYSE Regulation stating that it had accepted the Company’s plan to regain
compliance with the continued listing standards of the NYSE American LLC ("NYSE American").
The Company submitted a compliance
plan to NYSE American on April 24, 2026. NYSE Regulation accepted the plan and granted the Company a plan period through September 25,
2027 to regain compliance with the applicable continued listing standards.
As previously disclosed, on March
25, 2026, the Company received written notice from NYSE Regulation that the Company was not in compliance with the continued listing standards
set forth in Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the NYSE American LLC Company Guide (the “Company Guide”),
which require a listed company to maintain specified levels of stockholders’ equity. The notice was based on the Company’s
reported stockholders’ deficit of $(1,302,000) as of December 31, 2025 and its losses from continuing operations and/or net losses
in its five most recent fiscal years then ended. The Company was also not eligible for any exemption from the stockholders’ equity
requirements under Section 1003(a) of the Company Guide.
During the plan period, the Company’s
common stock will continue to be listed and traded on NYSE American, subject to the Company’s compliance with the initiatives and
conditions set forth in the compliance plan and continued periodic review by NYSE Regulation. Until the Company regains compliance, a
“.BC” (below compliance) indicator will be disseminated with the Company’s ticker symbol, and the Company will be included
on the NYSE American’s list of noncompliant issuers published on the Exchange’s website. If the Company does not regain compliance
with the applicable continued listing standards by the end of the plan period, or does not make progress consistent with the compliance
plan during the plan period, NYSE Regulation may initiate delisting proceedings.
The Company is committed to taking
the actions set forth in the plan and intends to use all reasonable efforts to regain compliance with the applicable continued listing
standards within the plan period. [The Company can provide no assurances that it will be able to make progress with respect to its Plan
that the NYSE Regulation will determine to be satisfactory, that it will regain compliance with Section 1003(a)(i), (ii) or (iii) of the
Company Guide during the Plan Period, or that developments and events occurring subsequent to the Company’s formulation of the Plan
or its acceptance by NYSE Regulation will not adversely affect the Company’s ability to make sufficient progress and/or regain compliance
with the aforementioned sections of the Company Guide during the Plan Period or result in the Company’s failure to be in compliance
with other NYSE American continued listing standards.
Item 7.01. Regulation FD Disclosure.
On June 12, 2026, the Company issued a press release
announcing that NYSE Regulation had accepted the plan. A copy of the press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K.
The information furnished under this Item 7.01, including
Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference
into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of BiomX Inc., dated June 12, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BiomX Inc.
Date: June 12, 2026
By:
/s/ Michael Oster
Name:
Michael Oster
Title:
Chief Executive Officer
2
EX-99.1 — PRESS RELEASE OF BIOMX INC., DATED JUNE 12, 2026
EX-99.1
Filename: ea029450701ex99-1.htm · Sequence: 2
Exhibit 99.1
BiomX Announces NYSE American Acceptance of
Plan to Regain Compliance
NETANYA, Israel, June 12, 2026 - BiomX Inc. (NYSE
American: PHGE) (“BiomX” or the “Company”) today announced that the Company’s previously-submitted plan
(the “Plan”) to regain compliance with NYSE American LLC’s listing standards was accepted, including plan compliance
period through September 25, 2027.
As previously reported, on March 25, 2026, the
Company received written notice from NYSE American that it was not in compliance with Sections 1003(a)(i), (ii), and (iii) of the NYSE
American Company Guide, which require a listed company to maintain specified levels of stockholders’ equity. The notice was based
on the Company’s reported stockholders’ deficit of $(1.302 million) as of December 31, 2025, and its losses from continuing
operations and/or net losses in its five most recent fiscal years then ended.
The Company submitted its Plan to NYSE Regulation
on April 24, 2026. On June 10, 2026, NYSE Regulation notified the Company that it had accepted the Plan and granted the Company a plan
period through September 25, 2027 to regain compliance with the applicable continued listing standards. During the plan period, the Company
will be subject to periodic review by NYSE Regulation for compliance with the initiatives set forth in the Plan.
The Company’s common stock will continue
to be listed and traded on the NYSE American during the plan period, subject to the Company’s compliance with the terms of the Plan
and the other continued listing standards of the NYSE American Company Guide.
The acceptance of the Plan does not affect the
Company’s business operations or its reporting obligations under the rules of the Securities and Exchange Commission. The Company
intends to take the actions set forth in its Plan to evidence compliance with the applicable continued listing standards within the plan
period.
About BiomX Inc.
BiomX Inc. is a company focused on acquiring and
further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure,
and first-response sectors. The Company’s portfolio is built around the growing need for earlier and more accurate threat detection,
particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
Forward-Looking Statements
This press release contains forward-looking statements
which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are “forward-looking statements”
within the meaning of the federal securities laws, including statements regarding BiomX’s ability to regain compliance with the
continued listing standards of the NYSE American, the Company’s ability to execute the initiatives set forth in its compliance plan,
the Company’s ability to maintain the listing of its common stock on the NYSE American during the plan period, and the Company’s
business strategy, financial position and strategic opportunities. In some cases, you can identify forward-looking statements by terminology
such as “will,” “would,” “expect,” “intend,” “plan,” “objective,”
“believe,” “anticipate,” or comparable terminology referencing future events, conditions or circumstances, or
the negative of such terms.
Although BiomX believes that it has a
reasonable basis for the forward-looking statements contained in this press release, they are based on management’s current
beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are
difficult to predict and many of which are beyond the Company’s control. Statements relating to the future performance of
BiomX are subject to many factors, including but not limited to the Company’s ability to regain compliance with NYSE American
continued listing standards within the applicable plan period, the possibility that NYSE Regulation may initiate delisting
proceedings if the Company does not regain compliance or make progress consistent with its compliance plan, the sufficiency of
working capital to realize the Company’s business plans and strategic opportunities, the going concern qualification in the
Company’s financial statements, the Company’s ability to integrate and further develop acquired technologies, market
acceptance and adoption of the Company’s technologies, competitive developments, changes in government and defense spending
priorities, regulatory, export-control and geopolitical developments, the Company’s ability to penetrate its intended markets
and execute its business strategy, and other risk factors. Risk factors described under “Risk Factors” in BiomX’s
most recently filed Annual Report on Form 10-K, as supplemented by the Form 10-K/A filed with the SEC on April 30, 2026, the Current
Report on Form 8-K filed with the SEC on May 5, 2026 and other filings with the Securities and Exchange Commission, may cause actual
results, performance, or achievements to differ materially from those expressed or implied by forward-looking statements in this
press release.
You are cautioned not to place undue reliance
on forward-looking statements, which speak only as of the date on which they were made. BiomX undertakes no obligation to update any forward-looking
statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release,
except as required by law.
Contact
Yair Ohayon
Yairo@biomx.com
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.1
Cover
Jun. 10, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Jun. 10, 2026
Entity File Number
001-38762
Entity Registrant Name
BIOMX INC.
Entity Central Index Key
0001739174
Entity Tax Identification Number
82-3364020
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
850 New Burton Road
Entity Address, Address Line Two
Suite 201
Entity Address, City or Town
Dover
Entity Address, State or Province
DE
Entity Address, Postal Zip Code
19904
City Area Code
972
Local Phone Number
52-437-4900
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, $0.0001 par value per share
Trading Symbol
PHGE
Security Exchange Name
NYSEAMER
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration